NCT00972504View on ClinicalTrials.gov

723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 1, 2009

Primary Completion Date

August 1, 2009

Study Completion Date

August 14, 2009

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

GSK835726 10mg

GSK835726 10mg tablet

DRUG

GSK1004723 1000mcg

GSK1004723 1000mcg nasal spray solution

DRUG

Cetirizine 10mg

Cetirizine 10mg active comparator

DRUG

placebo

placebo to match actives

Trial Locations (1)

30625

GSK Investigational Site, Hanover

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY